Burning Rock Biotech (BNR) Enterprise Value: 2020-2024
Historic Enterprise Value for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$71.5 million.
- Burning Rock Biotech's Enterprise Value rose 25.21% to -$65.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$65.6 million, marking a year-over-year increase of 25.21%. This contributed to the annual value of -$71.5 million for FY2024, which is 17.44% up from last year.
- According to the latest figures from FY2024, Burning Rock Biotech's Enterprise Value is -$71.5 million, which was up 17.44% from -$86.7 million recorded in FY2023.
- In the past 5 years, Burning Rock Biotech's Enterprise Value ranged from a high of -$71.5 million in FY2024 and a low of -$355.9 million during FY2020.
- Its 3-year average for Enterprise Value is -$97.4 million, with a median of -$86.7 million in 2023.
- In the last 5 years, Burning Rock Biotech's Enterprise Value surged by 42.82% in 2022 and then decreased by 17.44% in 2024.
- MRY analysis of 5 years shows Burning Rock Biotech's Enterprise Value stood at -$355.9 million in 2020, then soared by 34.08% to -$234.6 million in 2021, then soared by 42.82% to -$134.2 million in 2022, then surged by 35.41% to -$86.7 million in 2023, then increased by 17.44% to -$71.5 million in 2024.
- Its Enterprise Value stands at -$71.5 million for FY2024, versus -$86.7 million for FY2023 and -$134.2 million for FY2022.